Document Detail


Expression, purification, and inhibition of human RET tyrosine kinase.
MedLine Citation:
PMID:  15802236     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Tyrosine kinases are emerging as frequent targets of primary oncogenic events and therefore represent an optimal focus of therapeutical intervention. Genetic alterations that cause dysregulated activation of the RET tyrosine kinase are responsible for a significant fraction of thyroid carcinomas. In an effort towards therapeutic RET inactivation, we have developed a method for expression and purification of recombinant RET catalytic domain for structural purposes and for use in the screening of potential inhibitors of RET kinase activity. His-tagged RET kinase domain was purified from Sf9 insect cell lysate using a two-step chromatographic protocol and characterised. Purified recombinant RET phosphorylated itself and exogenous substrates at physiological pH. A specific peptide substrate, derived from RET activation loop, was identified and experimentally validated. These reagents were used to develop a rapid ELISA-based kinase assay for screening potential inhibitors. Novel RET inhibitors were identified using this assay.
Authors:
Luca Mologni; Elisa Sala; Barbara Riva; Luca Cesaro; Sara Cazzaniga; Sara Redaelli; Oriano Marin; Nicola Pasquato; Arianna Donella-Deana; Carlo Gambacorti-Passerini
Related Documents :
15044856 - Beyond the metabolic function of ptp1b.
15297606 - Regulation of signal transducer and activator of transcription 1 (stat1) and stat1-depe...
15798896 - Oxidation and tyrosine phosphorylation: synergistic or antagonistic cues in protein tyr...
9915856 - The kunitz protease inhibitor form of the amyloid precursor protein (kpi/app) inhibits ...
1312616 - V-src enhances phosphorylation at ser-282 of the rous sarcoma virus integrase.
16810256 - Nodulation independent of rhizobia induced by a calcium-activated kinase lacking autoin...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Protein expression and purification     Volume:  41     ISSN:  1046-5928     ISO Abbreviation:  Protein Expr. Purif.     Publication Date:  2005 May 
Date Detail:
Created Date:  2005-04-01     Completed Date:  2005-08-22     Revised Date:  2012-06-04    
Medline Journal Info:
Nlm Unique ID:  9101496     Medline TA:  Protein Expr Purif     Country:  United States    
Other Details:
Languages:  eng     Pagination:  177-85     Citation Subset:  IM    
Affiliation:
Department of Clinical Medicine, University of Milano-Bicocca, Monza, Italy. luca.mologni@unimib.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Sequence
Animals
Baculoviridae / genetics
Base Sequence
Catalytic Domain
Cell Line
DNA, Recombinant / genetics
Enzyme Inhibitors / chemistry,  pharmacology
Gene Expression
Humans
Molecular Sequence Data
Molecular Structure
Oncogene Proteins / antagonists & inhibitors,  genetics*,  isolation & purification*
Proto-Oncogene Proteins c-ret
Receptor Protein-Tyrosine Kinases / antagonists & inhibitors,  genetics*,  isolation & purification*
Recombinant Proteins / antagonists & inhibitors,  genetics,  isolation & purification
Spodoptera
Chemical
Reg. No./Substance:
0/DNA, Recombinant; 0/Enzyme Inhibitors; 0/Oncogene Proteins; 0/Recombinant Proteins; EC 2.7.10.1/Proto-Oncogene Proteins c-ret; EC 2.7.10.1/RET protein, human; EC 2.7.10.1/Receptor Protein-Tyrosine Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prokaryotic expression and polyclonal antibody preparation of novel ZLG10 protein involved in infect...
Next Document:  Refolding, purification, and crystallization of apical membrane antigen 1 from Plasmodium falciparum...